Home > Journals > Minerva Cardiology and Angiology > Past Issues > Articles online first > Minerva Cardiology and Angiology 2021 Jun 17

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

 

Minerva Cardiology and Angiology 2021 Jun 17

DOI: 10.23736/S2724-5683.21.05743-4

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Characterisation of haemodynamic and metabolic abnormalities in the heart failure spectrum: the role of combined cardiopulmonary and exercise echocardiography stress test

Nicola R. PUGLIESE 1 , Nicolò DE BIASE 1, Alessio BALLETTI 1, Francesco FILIDEI 1, Alessandra PIERONI 1, Gennaro D'ANGELO 2, Silvia ARMENIA 1, Matteo MAZZOLA 1, 2, Luna GARGANI 2, Lavinia DEL PUNTA 1, Muzaffar ASOMOV 1, Eugenio CERRI 1, Ferdinando FRANZONI 1, Lorenzo NESTI 1, Alessandro MENGOZZI 1, Francesco PANENI 3, Stefano MASI 1

1 Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 2 Institute of Clinical Physiology, C.N.R., Pisa, Italy; 3 Center for Molecular Cardiology, University of Zürich, Zürich, Switzerland


PDF


Heart failure (HF) is a complex clinical syndrome characterised by different etiologies and a broad spectrum of cardiac structural and functional abnormalities. Current guidelines suggest a classification based on left ventricular ejection fraction (LVEF), distinguishing HF with reduced (HFrEF) from preserved (HFpEF) LVEF. HF should also be thought of as a continuous range of conditions, from asymptomatic stages to clinically manifest syndrome. The transition from one stage to the next is associated with a worse prognosis. While the rate of HF-related hospitalisation is similar in HFrEF and HFpEF once clinical manifestations occur, accurate knowledge of the steps and risk factors leading to HF progression is still lacking, especially in HFpEF. Precise hemodynamic and metabolic characterisation of patients with or at risk of HF may help identify different disease trajectories and risk factors, with the potential to identify specific treatment targets that might offset the slippery slope towards overt clinical manifestations. Exercise can unravel early metabolic and haemodynamic alterations that might be silent at rest, potentially leading to improved risk stratification and more effective treatment strategies. Cardiopulmonary exercise testing (CPET) offers valuable aid to investigate functional alterations in subjects with or at risk of HF, while echocardiography can assess cardiac structure and function objectively, both at rest and during exercise (exercise stress echocardiography, ESE). The purpose of this narrative review is to summarise the potential advantages of using an integrated CPET-ESE evaluation in the characterisation of both subjects at risk of developing HF and patients with stable HF.


KEY WORDS: Heart failure; Cardiopulmonary exercise testing; Exercise stress echocardiography

top of page